PubRank

Liver cancer (Liver Cancer)

Journal PubWeight™ 113.39‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Treatment of hepatocellular carcinoma: a systematic review. 2012 1.47
2 Molecular biology of liver cancer stem cells. 2014 1.41
3 Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy. 2012 1.36
4 JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. 2014 1.35
5 Epidemiology and surveillance of hepatocellular carcinoma. 2012 1.32
6 Emerging signaling pathways in hepatocellular carcinoma. 2012 1.32
7 Chemoembolization in patients with hepatocellular carcinoma. 2012 1.27
8 Liver resection and transplantation in hepatocellular carcinoma. 2012 1.24
9 Local ablation for hepatocellular carcinoma in taiwan. 2013 1.21
10 Surgical and Locoregional Therapy of HCC: TACE. 2015 1.16
11 Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. 2015 1.12
12 Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC. 2015 1.10
13 Diagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current Consensus. 2014 1.10
14 How to define transarterial chemoembolization failure or refractoriness: a European perspective. 2014 1.10
15 Recent Advances in Tumor Ablation for Hepatocellular Carcinoma. 2015 1.08
16 Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future. 2014 1.07
17 From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence. 2013 1.05
18 Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china. 2013 1.05
19 A worldwide survey of the current daily practice in liver surgery. 2013 1.04
20 Drug therapy for advanced-stage liver cancer. 2014 1.03
21 Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma. 2012 1.02
22 Liver transplantation for hepatocellular carcinoma. 2013 1.01
23 Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis. 2014 1.01
24 Living donor liver transplantation for patients with hepatocellular carcinoma. 2014 1.00
25 Immunotherapeutic approaches to hepatocellular carcinoma treatment. 2012 1.00
26 Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. 2012 0.99
27 Clinical trials in hepatocellular carcinoma: an update. 2013 0.99
28 Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition. 2012 0.98
29 Japan's Successful Model of Nationwide Hepatocellular Carcinoma Surveillance Highlighting the Urgent Need for Global Surveillance. 2012 0.98
30 Clinical application of fluorescence imaging of liver cancer using indocyanine green. 2012 0.97
31 Locoregional Therapy for Hepatocellular Carcinoma. 2015 0.97
32 Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe. 2015 0.96
33 Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we? 2013 0.95
34 Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosis. 2014 0.95
35 Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma. 2015 0.95
36 Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation. 2015 0.94
37 New paradigm for management of hepatocellular carcinoma by imaging. 2012 0.92
38 Hepatic iron overload and hepatocellular carcinoma. 2014 0.92
39 Laparoscopic liver resection for hepatocellular carcinoma: korean experiences. 2013 0.92
40 Early hepatocellular carcinoma: definition and diagnosis. 2013 0.91
41 Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective. 2015 0.91
42 Portal vein embolization for hepatocellular carcinoma. 2012 0.90
43 Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus. 2013 0.89
44 Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging. 2012 0.88
45 Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography. 2014 0.88
46 Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials. 2016 0.87
47 Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma. 2012 0.87
48 Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry. 2015 0.86
49 Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. 2013 0.86
50 Biomarkers and Personalized Sorafenib Therapy. 2014 0.85
Next 50